StayHappi Ivabradine 5mg Tablet
Marketer
Sarvagunaushdhi Pvt Ltd
Salt Composition
Ivabradine (5mg)
Overview StayHappi Ivabradine 5mg Tablet
CardioLife Ivabradine 5mg tablets effectively manage angina pectoris (chest pain stemming from heart conditions) and persistent heart failure. By reducing heart rate, it enhances cardiac efficiency, mitigating chest discomfort and reducing hospital readmission risk in heart failure patients. Dosage is tailored to the specific condition. As treatment is typically ongoing, cessation requires physician consultation. Consistent daily intake with food is recommended. Overdosage can cause excessive heart rate slowing, leading to breathlessness or fatigue; seek immediate medical advice if this occurs. Common, typically transient, side effects include visual brightening, bradycardia, hypertension, atrial fibrillation, dizziness, blurred vision, and electrocardiogram alterations. Serious side effects like syncope and significant heart rhythm changes necessitate prompt medical attention. Refrain from driving until the drug's effects are known. Contraindicated in individuals with severe hepatic impairment, resting bradycardia, cardiac arrhythmias, severely low blood pressure, or recently exacerbated heart failure. Interactions exist with certain antihypertensives, antifungals, and antiretrovirals. Avoid use during pregnancy, attempts at conception, or breastfeeding.
Uses of StayHappi Ivabradine 5mg Tablet
Managing angina pectoris and heart failure.
Major Benefits of StayHappi Ivabradine 5mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The StayHappi Ivabradine 5mg Tablet should be administered with a meal.
Common Side effects of StayHappi Ivabradine 5mg Tablet:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use StayHappi Ivabradine 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the StayHappi Ivabradine 5mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How StayHappi Ivabradine 5mg Tablet works:
CardioRhythm Ivabradine 5mg tablets decrease heart rate, thereby reducing the heart's oxygen demand and improving its overall efficiency.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining alcohol with StayHappi Ivabradine 5mg Tablet is undetermined. Seek medical advice before combining them.
PregnancyUNSAFE
The use of StayHappi Ivabradine 5mg tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician, as research in animals and humans indicates substantial risks to fetal development.
Breast feedingUNSAFE
Using StayHappi Ivabradine 5mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Ivabradine 5mg tablets (StayHappi brand) can induce adverse reactions that may impair driving ability. These may include transient visual disturbances, primarily phosphenes. The potential for such light flashes should be considered, particularly during nighttime driving.
KidneyCAUTION
Patients with severe kidney impairment should use StayHappi Ivabradine 5mg Tablets cautiously, as dose modification may be necessary. Consult a physician for guidance. Data regarding StayHappi Ivabradine 5mg Tablet use in this patient population is limited.
LiverCAUTION
Ivabradine 5mg (StayHappi) requires careful consideration in patients with hepatic impairment; dosage modification may be necessary. Consult your physician. StayHappi Ivabradine 5mg is contraindicated in those with severe liver disease.
What if you forget to take StayHappi Ivabradine 5mg Tablet :
Omit any missed StayHappi Ivabradine 5mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About StayHappi Ivabradine 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzazepine compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Behavior Class | Sinoatrial node I<sub>f</sub> sodium channel blockers |
3,018 People bought this recently